Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Wright

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Neurochemistry International|November 27, 2013
Transgenic overexpression of the presynaptic choline transporter elevates acetylcholine levels and augments motor enduranceEricka C Holmstrand, David Lund, Ajeesh Koshy Cherian, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 6, 2010
Tachycardia, reduced vagal capacity, and age-dependent ventricular dysfunction arising from diminished expression of the presynaptic choline transporterBrett A English, Martin Appalsamy, Andre Diedrich, et al.
Molecular Omics|June 6, 2018
Global untargeted serum metabolomic analyses nominate metabolic pathways responsive to loss of expression of the orphan metallo β-lactamase, MBLAC1Chelsea L Gibson, Simona G Codreanu, Alexandra C Schrimpe-Rutledge, et al.
Molecular and Cellular Neurosciences|December 4, 2016
Sequence determinants of the Caenhorhabditis elegans dopamine transporter dictating in vivo axonal export and synaptic localizationSarah B Robinson, J Andrew Hardaway, Shannon L Hardie, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2016
Optimization of the choline transporter (CHT) inhibitor ML352: Development of VU6001221, an improved in vivo tool compoundJeanette L Bertron, Elizabeth A Ennis, Christopher J Tarr, et al.
ACS Chemical Neuroscience|October 19, 2012
Nonoisotopic assay for the presynaptic choline transporter reveals capacity for allosteric modulation of choline uptakeAlicia M Ruggiero, Jane Wright, Shawn M Ferguson, et al.
ACS Chemical Neuroscience|January 7, 2015
Identification and characterization of ML352: a novel, noncompetitive inhibitor of the presynaptic choline transporterElizabeth A Ennis, Jane Wright, Cassandra L Retzlaff, et al.
Journal of Infection Prevention|February 6, 2019
An evaluation of an infection prevention link nurse programme in community hospitals and development of an implementation modelLynne Williams, Tracey Cooper, Lisa Bradford, et al.
Molecular Brain|August 7, 2009
cGMP-dependent protein kinase Ialpha associates with the antidepressant-sensitive serotonin transporter and dictates rapid modulation of serotonin uptakeJennifer A Steiner, Ana Marin D Carneiro, Jane Wright, et al.
Blood|December 6, 2021
Redefining nonmeasurable multiple myeloma using mass spectrometryHannah V Giles, Mark A Cook, Mark Trehane Drayson, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Neurochemistry International|November 27, 2013
Transgenic overexpression of the presynaptic choline transporter elevates acetylcholine levels and augments motor enduranceEricka C Holmstrand, David Lund, Ajeesh Koshy Cherian, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 6, 2010
Tachycardia, reduced vagal capacity, and age-dependent ventricular dysfunction arising from diminished expression of the presynaptic choline transporterBrett A English, Martin Appalsamy, Andre Diedrich, et al.
Molecular Omics|June 6, 2018
Global untargeted serum metabolomic analyses nominate metabolic pathways responsive to loss of expression of the orphan metallo β-lactamase, MBLAC1Chelsea L Gibson, Simona G Codreanu, Alexandra C Schrimpe-Rutledge, et al.
Molecular and Cellular Neurosciences|December 4, 2016
Sequence determinants of the Caenhorhabditis elegans dopamine transporter dictating in vivo axonal export and synaptic localizationSarah B Robinson, J Andrew Hardaway, Shannon L Hardie, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2016
Optimization of the choline transporter (CHT) inhibitor ML352: Development of VU6001221, an improved in vivo tool compoundJeanette L Bertron, Elizabeth A Ennis, Christopher J Tarr, et al.
ACS Chemical Neuroscience|October 19, 2012
Nonoisotopic assay for the presynaptic choline transporter reveals capacity for allosteric modulation of choline uptakeAlicia M Ruggiero, Jane Wright, Shawn M Ferguson, et al.
ACS Chemical Neuroscience|January 7, 2015
Identification and characterization of ML352: a novel, noncompetitive inhibitor of the presynaptic choline transporterElizabeth A Ennis, Jane Wright, Cassandra L Retzlaff, et al.
Journal of Infection Prevention|February 6, 2019
An evaluation of an infection prevention link nurse programme in community hospitals and development of an implementation modelLynne Williams, Tracey Cooper, Lisa Bradford, et al.
Molecular Brain|August 7, 2009
cGMP-dependent protein kinase Ialpha associates with the antidepressant-sensitive serotonin transporter and dictates rapid modulation of serotonin uptakeJennifer A Steiner, Ana Marin D Carneiro, Jane Wright, et al.
Blood|December 6, 2021
Redefining nonmeasurable multiple myeloma using mass spectrometryHannah V Giles, Mark A Cook, Mark Trehane Drayson, et al.
Pageof 6